Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−86 JPY
−1.15 B JPY
1.63 B JPY
16.55 M
About CARNA BIOSCIENCES INC
Sector
Industry
Headquarters
Kobe
Website
Founded
2003
ISIN
JP3220550002
FIGI
BBG000P46DG1
Carna Biosciences, Inc. engages in the drug discovery business. It operates through the Drug Discovery Support and Drug Discovery and Development segments. The Drug Discovery Support segment provides drug discovery supporting products and services such as kinase protein, profiling services, assay development, crystallography, and cell-based assay services. The Drug Discovery and Development segment develops new medicines for the treatment of cancer and inflammatory diseases using the kinase drug discovery platform called QuickScout. The company was founded on April 10, 2003 and is headquartered in Kobe, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4572 is 310 JPY — it has decreased by −0.32% in the past 24 hours. Watch CARNA BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CARNA BIOSCIENCES INC stocks are traded under the ticker 4572.
4572 stock has risen by 5.08% compared to the previous week, the month change is a −2.82% fall, over the last year CARNA BIOSCIENCES INC has showed a −62.52% decrease.
4572 reached its all-time high on Jul 23, 2015 with the price of 6,030 JPY, and its all-time low was 195 JPY and was reached on Oct 8, 2008. View more price dynamics on 4572 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4572 stock is 2.62% volatile and has beta coefficient of 0.88. Track CARNA BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is CARNA BIOSCIENCES INC there?
Today CARNA BIOSCIENCES INC has the market capitalization of 5.92 B, it has increased by 8.36% over the last week.
Yes, you can track CARNA BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
CARNA BIOSCIENCES INC is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4572 net income for the last quarter is −494.47 M JPY, while the quarter before that showed −695.23 M JPY of net income which accounts for 28.88% change. Track more CARNA BIOSCIENCES INC financial stats to get the full picture.
No, 4572 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 67.00 employees. See our rating of the largest employees — is CARNA BIOSCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARNA BIOSCIENCES INC EBITDA is −1.46 B JPY, and current EBITDA margin is −66.51%. See more stats in CARNA BIOSCIENCES INC financial statements.
Like other stocks, 4572 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARNA BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARNA BIOSCIENCES INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARNA BIOSCIENCES INC stock shows the sell signal. See more of CARNA BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.